​

Krystal Biotech Ownership | Who Owns Krystal Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary


Krystal Biotech is owned by 100.60% institutional investors, 10.64% insiders. Fmr is the largest institutional shareholder, holding 15.04% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.09% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKrystal Biotech100.60%10.64%-11.24%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.44M15.04%$1.48B
Blackrock3.95M13.95%$724.98M
Blackrock funding, inc. /de3.59M12.16%$1.19B
Avoro capital advisors2.89M9.86%$1.07B
Vanguard group2.78M9.60%$685.10M
State street1.42M4.81%$472.26M
Vanguard portfolio management1.29M4.36%$427.96M
Vanguard capital management1.20M4.05%$397.97M
Soleus capital management939.25K3.21%$349.09M
Geode capital management811.74K2.75%$270.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group632.00K15.77%$234.90M
Soleus capital management939.25K12.03%$349.09M
Act capital management45.00K10.93%$16.73M
Avoro capital advisors2.89M9.64%$1.07B
Act capital partners42.00K9.07%$13.97M
S squared77.55K8.94%$28.82M
Vestor capital700.91K4.91%$78.19M
Evolutionary tree capital management7.13K4.40%$2.37M
Frazier life sciences management481.31K3.90%$178.89M
Biondo investment advisors71.23K2.82%$23.69M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Norges bank259.03K0.01%259.03K
Price t rowe associates inc /md/687.40K0.03%202.33K
Geode capital management811.74K0.01%112.74K
Franklin resources370.95K0.02%109.03K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de3.59M0.02%-590.80K
Bellevue group77.53K0.61%-404.25K
Vanguard portfolio management1.29M0.02%-288.05K
First trust advisors lp49.27K0.01%-275.63K
Sixth street partners management company---254.83K

New Positions

HolderShares% AssetsChangeValue
Norges bank259.03K0.01%259.03K$96.27M
Capital impact advisors80.08K2.30%80.08K$26.63M
Eagle asset management76.26K0.07%76.26K$13.90M
Lord, abbett71.25K0.07%71.25K$23.69M
Act capital partners42.00K9.07%42.00K$13.97M

Sold Out

HolderChange
Tfc financial management-1.00
Tradewinds capital management-1.00
Ameritas advisory services-1.00
Davis capital management-1.00
Abound wealth management-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20264654.97%29,707,231-2.78%1000.92%263-3.66%1227.02%
Jun 30, 202643514.47%30,510,9297.56%1041.08%26824.65%1104.76%
Mar 31, 2026234-31.78%12,018,941-57.72%410.43%135-30.77%60-43.40%
Dec 31, 2025232-22.15%16,100,358-42.52%550.59%128-16.88%74-12.94%
Sep 30, 20252894.33%27,787,3363.78%961.12%1497.19%83-10.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Select Biotechnology1.80M6.09%-
iShares Core S&P Small-Cap ETF1.58M5.36%222.00
Fidelity Growth Compy Commingled Pl S1.07M3.62%20.90K
iShares Core S&P Mid-Cap ETF957.57K3.23%504.00
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
Vanguard Total Stock Mkt Idx Inv889.73K3.02%51.28K
Vanguard Morn Total Stk Mkt Idx Investor889.73K3.02%51.28K
Vanguard MStar Total Stk Mkt Idx Invest848.20K2.87%-43.23K
Vanguard US Total Market Shares ETF824.72K2.86%704.00
Fidelity Growth Company Fund816.13K2.76%6.63K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 04, 2026Krishnan Suma President, R&DSell$1.16M
Sep 04, 2026Krishnan Suma President, R&DSell$1.42M
Sep 04, 2026Krishnan Suma President, R&DSell$184.36K
Sep 04, 2026Krishnan Suma President, R&DSell$713.28K
Sep 04, 2026Krishnan Suma President, R&DSell$1.14M

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3-34
2026 Q2-24
2026 Q1-52
2025 Q4-32

KRYS Ownership FAQ


Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 100.60%, followed by 10.64% insiders and -11.24% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 181.42%, which Krystal Biotech falls below.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.44M shares, 15.04%), Blackrock (3.95M shares, 13.95%), and Blackrock funding, inc. /de (3.59M shares, 12.16%). Together, they hold 41.15% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Redmile group is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 15.77% of its assets in 632K Krystal Biotech shares, valued at 234.9M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.09% of its total shares outstanding invested in 1.8M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools